Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT

Journal of Clinical Lipidology

Volumn 10, Issue 1, 2016, Pages 15-32

  Bays, Harold E ^a   Jones, Peter H ^b   Jacobson, Terry A ^c   Cohen, David E ^d   Orringer, Carl E ^e   Kothari, Shanu ^f   Azagury, Dan E ^g   Morton, John ^g   Nguyen, Ninh T ^h   Westman, Eric C ⁱ   Horn, Deborah B ^j   Scinta, Wendy ^k   Primack, Craig ^l  

^a LOUISVILLE METABOLIC AND ATHEROSCLEROSIS RESEARCH CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF MIAMI HOSPITAL   (United States)

^f GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^j UNIVERSITY OF TEXAS   (United States)

^k Scottsdale Weight Loss ^*  (United States)

^l Scottsdale Weight Loss   (United States)

more..

Author keywords

Adiposopathy; Bariatric procedure; Bariatric surgery; Cholesterol; Lipids; Obesity; Scientific statement

Indexed keywords

BILE ACID; CARBOHYDRATE; CHOLESTEROL; FAT; GASTROINTESTINAL HORMONE; LIPID; MINERAL; PROTEIN; TRACE ELEMENT; VITAMIN;

ADIPOSE TISSUE; BARIATRIC SURGERY; BILE ACID METABOLISM; CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INTESTINE FLORA; LIPID ANALYSIS; LIPID TRANSPORT; LIPOGENESIS; MEDICAL SOCIETY; MINERAL DEFICIENCY; NUTRIENT; OBESITY; PRIORITY JOURNAL; REVIEW; VITAMIN DEFICIENCY;

EID: 84958891221     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.12.003     Document Type: Article

References (205)

1. S.M. Grundy Statins: definitive translational research Mol Med 20 Suppl 1 2014 S20 S23
2. H.E. Bays, B. Laferrere, J. Dixon, and et al. Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? Int J Clin Pract 63 2009 1285 1300
3. A.P. Courcoulas, S.Z. Yanovski, D. Bonds, and et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium JAMA Surg 149 2014 1323 1329
4. S. Appachi, and S.R. Kashyap 'Adiposopathy' and cardiovascular disease: the benefits of bariatric surgery Curr Opin Cardiol 28 2013 540 546
5. S. Appachi, K.R. Kelly, P.R. Schauer, and et al. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy" Obes Surg 21 2011 1928 1936
6. D.T. Ngo, M.G. Farb, R. Kikuchi, and et al. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity Circulation 130 2014 1072 1080
7. M.E. Piche, A. Auclair, J. Harvey, S. Marceau, and P. Poirier How to choose and use bariatric surgery in 2015 Can J Cardiol 31 2015 153 166
8. H.E. Bays Adiposopathy is "sick fat" a cardiovascular disease? J Am Coll Cardiol 57 2011 2461 2473
9. H.E. Bays, P.H. Jones, W.V. Brown, and T.A. Jacobson National lipid association annual summary of clinical lipidology 2015 J Clin Lipidol 8 2014 S1 S36
10. R. Berry, E. Jeffery, and M.S. Rodeheffer Weighing in on adipocyte precursors Cell Metab 19 2014 8 20
11. H.E. Bays, P.P. Toth, P.M. Kris-Etherton, and et al. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association J Clin Lipidol 7 2013 304 383
12. S. Prattes, G. Horl, A. Hammer, and et al. Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures J Cell Sci 113 Pt 17 2000 2977 2989
13. J. Farkas, A. Angel, and M.I. Avigan Studies on the compartmentation of lipid in adipose cells. II. Cholesterol accumulation and distribution in adipose tissue components J Lipid Res 14 1973 344 356
14. J.M. Dietschy, S.D. Turley, and D.K. Spady Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans J Lipid Res 34 1993 1637 1659
15. A.J. Murphy, and L. Yvan-Charvet Adipose modulation of ABCG1 uncovers an intimate link between sphingomyelin and triglyceride storage Diabetes 64 2015 689 692
16. B.R. Krause, and A.D. Hartman Adipose tissue and cholesterol metabolism J Lipid Res 25 1984 97 110
17. P.T. Kovanen, E.A. Nikkila, and T.A. Miettinen Regulation of cholesterol synthesis and storage in fat cells J Lipid Res 16 1975 211 223
18. F.B. Kraemer, S.A. Sather, B. Park, and et al. Low density lipoprotein receptors in rat adipose cells: subcellular localization and regulation by insulin J Lipid Res 35 1994 1760 1772
19. S. Fazio, and M.F. Linton Unique pathway for cholesterol uptake in fat cells Arterioscler Thromb Vasc Biol 24 2004 1538 1539
20. J.R. Crouse, S.M. Grundy, and E.H. Ahrens Jr. Cholesterol distribution in the bulk tissues of man: variation with age J Clin Invest 51 1972 1292 1296
21. S. Peng, W. Guo, J.D. Morrisett, M.T. Johnstone, and J.A. Hamilton Quantification of cholesteryl esters in human and rabbit atherosclerotic plaques by magic-angle spinning (13)C-NMR Arterioscler Thromb Vasc Biol 20 2000 2682 2688
22. Seger JC, H D, Westman EC, Lindquist R, Scinta W, Richardson LA, Primack C, Bryman DA, McCarthy W, Hendricks E, Sabowitz BN, Schmidt SL, Bays HE. Obesity Algorithm, presented by the American Society of Bariatric Physicians. www.obesityalgorithm.org. Version 2013-2014. Available at: www.obesityalgorithm.org. Accessed January 31, 2014.
23. H. Bays Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction Curr Opin Endocrinol Diabetes Obes 21 2014 345 351
24. E. Rath, and D. Haller Inflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologies Eur J Nutr 50 2011 219 233
25. R. Schinzel, and A. Dillin Endocrine aspects of organelle stress-cell non-autonomous signaling of mitochondria and the ER Curr Opin Cell Biol 33 2015 102 110
26. P. Pettinelli, and L.A. Videla Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction J Clin Endocrinol Metab 96 2011 1424 1430
27. T. Wadden, and A.J. Stunkard Handbook of Obesity Treatment 2002 The Guilford Press New York, NY
28. K.L. Spalding, E. Arner, P.O. Westermark, and et al. Dynamics of fat cell turnover in humans Nature 453 2008 783 787
29. A. Rigamonti, K. Brennand, F. Lau, and C.A. Cowan Rapid cellular turnover in adipose tissue PLoS One 6 2011 e17637
30. L. Heilbronn, S.R. Smith, and E. Ravussin Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus Int J Obes Relat Metab Disord 28 Suppl 4 2004 S12 S21
31. M. Bluher Adipose tissue dysfunction contributes to obesity related metabolic diseases Best Pract Res Clin Endocrinol Metab 27 2013 163 177
32. I. Moreno-Indias, and F.J. Tinahones Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders J Diabetes Res 2015 2015 970375
33. H. Bays Adiposopathy, "sick fat," ockham's razor, and resolution of the obesity paradox Curr Atheroscler Rep 16 2014 409
34. M. Brault, J. Ray, Y.H. Gomez, C.S. Mantzoros, and S.S. Daskalopoulou Statin treatment and new-onset diabetes: a review of proposed mechanisms Metabolism 63 2014 735 745
35. T. Mazurek, and G. Opolski Pericoronary adipose tissue: a novel therapeutic target in obesity-related coronary atherosclerosis J Am Coll Nutr 34 2015 244 254
36. M.L. Higuchi, P.S. Gutierrez, H.G. Bezerra, and et al. Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries Arq Bras Cardiol 79 2002 20 24
37. J. Yang, J. Kang, and Y. Guan The mechanisms linking adiposopathy to type 2 diabetes Front Med 7 2013 433 444
38. M.Z. Allende-Vigo Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk Endocr Pract 16 2010 692 698
39. H.E. Bays Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating "sick fat" through improving fat function with antidiabetes therapies Am J Cardiol 110 2012 4B 12B
40. H. Bays, N. Abate, and M. Chandalia Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia Future Cardiol 1 2005 39 59
41. H. Bays, and C. Ballantyne Adiposopathy: why do adiposity and obesity cause metabolic disease? Future Lipidol 1 2006 389 420
42. H.E. Bays, J.M. Gonzalez-Campoy, R.R. Henry, and et al. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract 62 2008 1474 1483
43. D.P. Andersson, D. Eriksson Hogling, A. Thorell, and et al. Changes in subcutaneous fat cell volume and insulin sensitivity after weight loss Diabetes Care 37 2014 1831 1836
44. M. Ryden, D.P. Andersson, I.B. Bergstrom, and P. Arner Adipose tissue and metabolic alterations: regional differences in fat cell size and number matter, but differently: a cross-sectional study J Clin Endocrinol Metab 99 2014 E1870 E1876
45. P. Singh, V.K. Somers, A. Romero-Corral, and et al. Effects of weight gain and weight loss on regional fat distribution Am J Clin Nutr 96 2012 229 233
46. M.I. Gurr, R.T. Jung, M.P. Robinson, and W.P. James Adipose tissue cellularity in man: the relationship between fat cell size and number, the mass and distribution of body fat and the history of weight gain and loss Int J Obes 6 1982 419 436
47. F. Ginsberg-Fellner, and J.L. Knittle Weight reduction in young obese children. I. Effects on adipose tissue cellularity and metabolism Pediatr Res 15 1981 1381 1389
48. A. Cotillard, C. Poitou, A. Torcivia, and et al. Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass J Clin Endocrinol Metab 99 2014 E1466 E1470
49. A. Wree, M. Schlattjan, L.P. Bechmann, and et al. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients Metabolism 63 2014 1542 1552
50. H.E. Bays, J.M. Gonzalez-Campoy, G.A. Bray, and et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity Expert Rev Cardiovasc Ther 6 2008 343 368
51. X. Shuai, K. Tao, M. Mori, and T. Kanda Bariatric surgery for metabolic syndrome in obesity Metab Syndr Relat Disord 13 2015 149 160
52. L.D. van Schinkel, M.A. Sleddering, M.A. Lips, and et al. Effects of bariatric surgery on pericardial ectopic fat depositions and cardiovascular function Clin Endocrinol 81 2014 689 695
53. B. Gaborit, A. Jacquier, F. Kober, and et al. Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content J Am Coll Cardiol 60 2012 1381 1389
54. M. Kaushik, and Y.M. Reddy Distinction of "fat around the heart" J Am Coll Cardiol 58 2011 1640 author reply 1640-1641
55. R. Nadeem, M. Singh, M. Nida, and et al. Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis J Clin Sleep Med 10 2014 475 489
56. M. Murri, E. Garcia-Fuentes, J.M. Garcia-Almeida, and et al. Changes in oxidative stress and insulin resistance in morbidly obese patients after bariatric surgery Obes Surg 20 2010 363 368
57. N. Gletsu-Miller, J.M. Hansen, D.P. Jones, and et al. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery Obesity (Silver Spring) 17 2009 439 446
58. S. Tangvarasittichai Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus World J Diabetes 6 2015 456 480
59. S. Le Lay, G. Simard, M.C. Martinez, and R. Andriantsitohaina Oxidative stress and metabolic pathologies: from an adipocentric point of view Oxid Med Cell Longev 2014 2014 908539
60. M.F. Gregor, and G.S. Hotamisligil Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease J Lipid Res 48 2007 1905 1914
61. L.L. Roberson, E.C. Aneni, W. Maziak, and et al. Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality - a systematic review BMC Public Health 14 2014 14
62. C.K. Kramer, B. Zinman, and R. Retnakaran Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis Ann Intern Med 159 2013 758 769
63. H.E. Bays "Sick fat," metabolic disease, and atherosclerosis Am J Med 122 2009 S26 S37
64. H. Buchwald, Y. Avidor, E. Braunwald, and et al. Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737
65. T.A. Jacobson, M.K. Ito, K.C. Maki, and et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1-executive summary J Clin Lipidol 8 2014 473 488
66. N.J. Stone, J. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines J Am Coll Cardiol 63 2014 2889 2934
67. H.E. Bays, D. Neff, J.E. Tomassini, and A.M. Tershakovec Ezetimibe: cholesterol lowering and beyond Expert Rev Cardiovasc Ther 6 2008 447 470
68. G.M. Cooper The Cell: A Molecular Approach 2nd ed 2000 Sinauer Associates Sunderland (MA) Available at: http://www.ncbi.nlm.nih.gov/books/NBK9928 Accessed January 10, 2016
69. H. Ohvo-Rekila, B. Ramstedt, P. Leppimaki, and J.P. Slotte Cholesterol interactions with phospholipids in membranes Prog Lipid Res 41 2002 66 97
70. L. Rossmeislova, L. Malisova, J. Kracmerova, and et al. Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile Diabetes 62 2013 1990 1995
71. M.C. Mitterberger, M. Mattesich, and W. Zwerschke Bariatric surgery and diet-induced long-term caloric restriction protect subcutaneous adipose-derived stromal/progenitor cells and prolong their life span in formerly obese humans Exp Gerontol 56 2014 106 113
72. H. Han, C. Hu, L. Wang, and et al. Duodenal-jejunal bypass surgery suppresses hepatic de novo lipogenesis and alleviates liver fat accumulation in a diabetic rat model Obes Surg 24 2014 2152 2160
73. M. Kolehmainen, H. Vidal, E. Alhava, and M.I. Uusitupa Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity Obes Res 9 2001 706 712
74. A.M. Adedayo, O. Olafiranye, D. Smith, and et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism Sleep Breath 18 2014 13 18
75. K.B. Cullberg, T. Christiansen, S.K. Paulsen, J.M. Bruun, S.B. Pedersen, and B. Richelsen Effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects Obesity (Silver Spring) 21 2013 454 460
76. Y.J. Lee, Y.S. Heo, H.S. Park, S.H. Lee, S.K. Lee, and Y.J. Jang Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults Obes Surg 24 2014 604 610
77. E.C. Mariman, and P. Wang Adipocyte extracellular matrix composition, dynamics and role in obesity Cell Mol Life Sci 67 2010 1277 1292
78. E. Pardina, A. Lecube, R. Llamas, and et al. Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients Obes Surg 19 2009 1150 1158
79. M.N. Munkonda, J. Martin, P. Poirier, and et al. Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women Nutr Diabetes 2 2012 e41
80. J.M. Moreno-Navarrete, F. Ortega, M. Serrano, and et al. CIDEC/FSP27 and PLIN1 gene expression run in parallel to mitochondrial genes in human adipose tissue, both increasing after weight loss Int J Obes (Lond) 38 2014 865 872
81. L. Garrido-Sanchez, J. Vendrell, D. Fernandez-Garcia, and et al. De novo lipogenesis in adipose tissue is associated with course of morbid obesity after bariatric surgery PLoS One 7 2012 e31280
82. N. Garcia de la Torre, M.A. Rubio, E. Bordiu, and et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin J Clin Endocrinol Metab 93 2008 4276 4281
83. H.E. Bays, and R.B. Goldberg The 'forgotten' bile acid sequestrants: is now a good time to remember? Am J Ther 14 2007 567 580
84. T. Ide, Y. Gotoh, and M. Sugano Dietary regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase and cholesterol synthetic activities in fasted-refed rats J Nutr 110 1980 158 168
85. J.M. Dietschy, and M.D. Siperstein Effect of cholesterol feeding and fasting on sterol synthesis in seventeen tissues of the rat J Lipid Res 8 1967 97 104
86. M. Patalay, I.E. Lofgren, H.C. Freake, S.I. Koo, and M.L. Fernandez The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase J Nutr 135 2005 735 739
87. L. Berglund, and D. Hyson Cholesterol absorption and the metabolic syndrome: a new look at an old area Arterioscler Thromb Vasc Biol 23 2003 1314 1316
88. G.C. Ness, and C.M. Chambers Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity Proc Soc Exp Biol Med 224 2000 8 19
89. P. Simonen, H. Gylling, A.N. Howard, and T.A. Miettinen Introducing a new component of the metabolic syndrome: low cholesterol absorption Am J Clin Nutr 72 2000 82 88
90. P. Methlie, S. Dankel, T. Myhra, and et al. Changes in adipose glucocorticoid metabolism before and after bariatric surgery assessed by direct hormone measurements Obesity (Silver Spring) 21 2013 2495 2503
91. J.D. Horton, J.C. Cohen, and H.H. Hobbs Molecular biology of PCSK9: its role in LDL metabolism Trends Biochem Sci 32 2007 71 77
92. I. Jialal, and S.B. Patel PCSK9 Inhibitors: The Next Frontier in Low-Density Lipoprotein Lowering Metab Syndr Relat Disord 13 2015 99 101
93. L. Izem, and R.E. Morton Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage J Biol Chem 282 2007 21856 21865
94. A. Benetti, M. Del Puppo, A. Crosignani, and et al. Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures Diabetes care 36 2013 1443 1447
95. M.D. Jensen, D.H. Ryan, C.M. Apovian, and et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society J Am Coll Cardiol 63 2014 2985 3023
96. B. Cariou, M. LeBras, E. Letessier, and et al. Abstract 131: PCSK9: A Biomarker Associated with the Metabolic Complications of Morbid Obesity Arterioscler Thromb Vasc Biol 32 2012 A131
97. C. Richard, P. Couture, S. Desroches, and et al. Effect of the Mediterranean diet with and without weight loss on surrogate markers of cholesterol homeostasis in men with the metabolic syndrome Br J Nutr 107 2012 705 711
98. J. Aron-Wisnewsky, Z. Julia, C. Poitou, and et al. Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women J Clin Endocrinol Metab 96 2011 1151 1159
99. B.F. Asztalos, M.M. Swarbrick, E.J. Schaefer, and et al. Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women J Lipid Res 51 2010 2405 2412
100. L. Knosgaard, S.B. Thomsen, M. Stockel, H. Vestergaard, and A. Handberg Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals Nutr Diabetes 4 2014 e114
101. A.D. Miras, and C.W. le Roux Bariatric surgery and taste: novel mechanisms of weight loss Curr Opin Gastroenterol 26 2010 140 145
102. K. Gertow, K.H. Pietilainen, H. Yki-Jarvinen, and et al. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance Diabetologia 47 2004 1118 1125
103. M. Andersen, B. Lenhard, C. Whatling, P. Eriksson, and J. Odeberg Alternative promoter usage of the membrane glycoprotein CD36 BMC Mol Biol 7 2006 8
104. J. Li, Y. Wang, Y. Zhou, and J. Liu Gastric bypass surgery alters the mechanisms of insulin resistance in the adipose tissue of GK rats Mol Med Rep 6 2012 1111 1116
105. D.J. McNamara Dietary cholesterol, heart disease risk and cognitive dissonance Proc Nutr Soc 73 2014 161 166
106. J. Pihlajamaki, S. Gronlund, M. Simonen, and et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding Metabolism 59 2010 866 872
107. M.C. Phillips Molecular mechanisms of cellular cholesterol efflux J Biol Chem 289 2014 24020 24029
108. M. Raffaelli, A. Iaconelli, G. Nanni, and et al. Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels Br J Surg 102 2015 682 690
109. P.F. Finn, and J.F. Dice Proteolytic and lipolytic responses to starvation Nutrition 22 2006 830 844
110. G.M. Campos, C. Rabl, P.J. Havel, and et al. Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery Surg Obes Relat Dis 10 2014 1 8
111. A. Aminian, A. Zelisko, J.P. Kirwan, S.A. Brethauer, and P.R. Schauer Exploring the impact of bariatric surgery on high density lipoprotein Surg Obes Relat Dis 11 2015 238 247
112. A.D. Sniderman, T. Scantlebury, and K. Cianflone Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus Ann Intern Med 135 2001 447 459
113. H.M. Heneghan, H. Huang, S.R. Kashyap, and et al. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio Surg Obes Relat Dis 9 2013 100 107
114. N. Padilla, M. Maraninchi, S. Beliard, and et al. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans Arterioscler Thromb Vasc Biol 34 2014 2330 2337
115. B. Mittendorfer, B.W. Patterson, and S. Klein Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity Am J Physiol Endocrinol Metab 284 2003 E549 E556
116. E. Zvintzou, G. Skroubis, A. Chroni, and et al. Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial J Clin Lipidol 8 2014 408 417
117. S. Abu Abeid, A. Szold, N. Gavert, and et al. Apolipoprotein-E genotype and the risk of developing cholelithiasis following bariatric surgery: a clue to prevention of routine prophylactic cholecystectomy Obes Surg 12 2002 354 357
118. Z.H. Huang, R.M. Luque, R.D. Kineman, and T. Mazzone Nutritional regulation of adipose tissue apolipoprotein E expression Am J Physiol Endocrinol Metab 293 2007 E203 E209
119. S. Villeneuve, D. Brisson, N.L. Marchant, and D. Gaudet The potential applications of Apolipoprotein E in personalized medicine Front Aging Neurosci 6 2014 154
120. M. Van Eck HDL subpopulations: of mice and men Atherosclerosis 233 2014 45 47
121. M. Jamal, R. Wegner, D. Heitshusen, J. Liao, and I. Samuel Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data Surg Obes Relat Dis 7 2011 473 479
122. M. Vergeer, A.G. Holleboom, J.J. Kastelein, and J.A. Kuivenhoven The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 51 2010 2058 2073
123. H. Bays, J. McKenney, and M. Davidson Torcetrapib/atorvastatin combination therapy Expert Rev Cardiovasc Ther 3 2005 789 820
124. M.W. Laimer, J. Engl, A. Tschoner, and et al. Effects of weight loss on lipid transfer proteins in morbidly obese women Lipids 44 2009 1125 1130
125. S. Dogan, I. Aslan, R. Eryilmaz, C.O. Ensari, T. Bilecik, and M. Aslan Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy Obes Surg 23 2013 1973 1980
126. G.X. Shen, W. Cai, and A. Angel Increased secretion of cholesteryl ester transfer protein from hamster adipose tissue: stimulation by beta-adrenergic agents Atherosclerosis 140 1998 113 120
127. F.C. McGillicuddy, M.P. Reilly, and D.J. Rader Adipose modulation of high-density lipoprotein cholesterol: implications for obesity, high-density lipoprotein metabolism, and cardiovascular disease Circulation 124 2011 1602 1605
128. E.J. Tarling, T.Q. de Aguiar Vallim, and P.A. Edwards Role of ABC transporters in lipid transport and human disease Trends Endocrinol Metab 24 2013 342 350
129. M.M. Swarbrick, K.L. Stanhope, I.T. Austrheim-Smith, and et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery Diabetologia 51 2008 1901 1911
130. F.M. van Dielen, W.A. Buurman, M. Hadfoune, J. Nijhuis, and J.W. Greve Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery J Clin Endocrinol Metab 89 2004 4062 4068
131. N.T. Nguyen, C.D. Goldman, H.S. Ho, R.C. Gosselin, A. Singh, and B.M. Wolfe Systemic stress response after laparoscopic and open gastric bypass J Am Coll Surg 194 2002 557 566 discussion 566-557
132. H. Bays, L. Blonde, and R. Rosenson Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Expert Rev Cardiovasc Ther 4 2006 871 895
133. R. Yang, and L.A. Barouch Leptin signaling and obesity: cardiovascular consequences Circ Res 101 2007 545 559
134. N. Sainz, J. Barrenetxe, M.J. Moreno-Aliaga, and J.A. Martinez Leptin resistance and diet-induced obesity: central and peripheral actions of leptin Metabolism 64 2015 35 46
135. S.R. Rao Inflammatory markers and bariatric surgery: a meta-analysis Inflamm Res 61 2012 789 807
136. S.P. Zhao, and D.Q. Zhang Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits Clin Chim Acta 336 2003 103 108
137. D. Zhang, D. Che, S. Zhao, and Y. Sun Effects of atorvastatin on C-reactive protein secretions by adipocytes in hypercholesterolemic rabbits J Cardiovasc Pharmacol 50 2007 281 285
138. A.C. Paepegaey, L. Genser, J.L. Bouillot, J.M. Oppert, K. Clement, and C. Poitou High levels of CRP in morbid obesity: the central role of adipose tissue and lessons for clinical practice before and after bariatric surgery Surg Obes Relat Dis 11 2015 148 154
139. M.A. Trakhtenbroit, J.G. Leichman, M.F. Algahim, and et al. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery Am J Med 122 2009 435 442
140. N. Vilarrasa, J. Vendrell, R. Sanchez-Santos, and et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients Clin Endocrinol 67 2007 679 686
141. A. Tailleux, K. Rouskas, F. Pattou, and B. Staels Bariatric surgery, lipoprotein metabolism and cardiovascular risk Curr Opin Lipidol 26 2015 317 324
142. J.Y. Chiang Bile acids: regulation of synthesis J Lipid Res 50 2009 1955 1966
143. P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of bile acids and bile acid receptors in metabolic regulation Physiol Rev 89 2009 147 191
144. S.I. Sayin, A. Wahlstrom, J. Felin, and et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist Cell Metab 17 2013 225 235
145. H. Bays, and E.A. Stein Pharmacotherapy for dyslipidaemia-current therapies and future agents Expert Opin Pharmacother 4 2003 1901 1938
146. Z. Xiang, Y.P. Chen, K.F. Ma, and et al. The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review BMC Gastroenterol 13 2013 140
147. L.A. Woollett, D.D. Buckley, L. Yao, and et al. Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans J Lipid Res 44 2003 935 942
148. M. Mueller, A. Thorell, T. Claudel, and et al. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity J Hepatol 62 2015 1398 1404
149. M.G. Roma, F.D. Toledo, A.C. Boaglio, C.L. Basiglio, F.A. Crocenzi, and E.J. Sanchez Pozzi Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications Clin Sci (Lond) 121 2011 523 544
150. H.E. Bays, and D.E. Cohen Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus Curr Med Res Opin 23 2007 1673 1684
151. L.J. Bennion, and S.M. Grundy Effects of obesity and caloric intake on biliary lipid metabolism in man J Clin Invest 56 1975 996 1011
152. S.M. Post, H. Duez, P.P. Gervois, B. Staels, F. Kuipers, and H.M. Princen Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression Arterioscler Thromb Vasc Biol 21 2001 1840 1845
153. L.A. Woollett, D.D. Buckley, L. Yao, and et al. Cholic acid supplementation enhances cholesterol absorption in humans Gastroenterology 126 2004 724 731
154. M. Watanabe, S.M. Houten, L. Wang, and et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J Clin Invest 113 2004 1408 1418
155. I. Chennamsetty, T. Claudel, K.M. Kostner, and et al. Farnesoid X receptor represses hepatic human APOA gene expression J Clin Invest 121 2011 3724 3734
156. S. Fang, J.M. Suh, S.M. Reilly, and et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance Nat Med 21 2015 159 165
157. G. Rizzo, M. Disante, A. Mencarelli, and et al. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo Mol Pharmacol 70 2006 1164 1173
158. M. Abdelkarim, S. Caron, C. Duhem, and et al. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways J Biol Chem 285 2010 36759 36767
159. A.H. Ali, E.J. Carey, and K.D. Lindor Recent advances in the development of farnesoid X receptor agonists Ann Transl Med 3 2015 5
160. M.J. Evans, P.E. Mahaney, L. Borges-Marcucci, and et al. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia Am J Physiol Gastrointest Liver Physiol 296 2009 G543 G552
161. C. Gardes, E. Chaput, A. Staempfli, D. Blum, H. Richter, and G.M. Benson Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters J Lipid Res 54 2013 1283 1299
162. I. Quercia, R. Dutia, D.P. Kotler, S. Belsley, and B. Laferrere Gastrointestinal changes after bariatric surgery Diabetes Metab 40 2014 87 94
163. H. Bays, and P.H. Jones Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors Vasc Health Risk Manag 3 2007 733 742
164. H. Bays, and C. Dujovne Colesevelam HCl: a non-systemic lipid-altering drug Expert Opin Pharmacother 4 2003 779 790
165. R. Raghow Menage-a-trois of bariatric surgery, bile acids and the gut microbiome World J Diabetes 6 2015 367 370
166. K.K. Ryan, V. Tremaroli, C. Clemmensen, and et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy Nature 509 2014 183 188
167. D.C. Savage Microbial ecology of the gastrointestinal tract Annu Rev Microbiol 31 1977 107 133
168. K.H. Allin, T. Nielsen, and O. Pedersen Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus Eur J Endocrinol 172 2015 R167 R177
169. J.M. Ridlon, D.J. Kang, P.B. Hylemon, and J.S. Bajaj Bile acids and the gut microbiome Curr Opin Gastroenterol 30 2014 332 338
170. Y.J. Zhang, S. Li, R.Y. Gan, T. Zhou, D.P. Xu, and H.B. Li Impacts of Gut Bacteria on Human Health and Diseases Int J Mol Sci 16 2015 7493 7519
171. G. Musso, R. Gambino, and M. Cassader Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes care 33 2010 2277 2284
172. A.P. Liou, M. Paziuk, J.M. Luevano Jr., S. Machineni, P.J. Turnbaugh, and L.M. Kaplan Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity Sci Transl Med 5 2013 178ra141
173. R.E. Steinert, R. Peterli, S. Keller, and et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial Obesity (Silver Spring) 21 2013 E660 668
174. M. Million, J.C. Lagier, D. Yahav, and M. Paul Gut bacterial microbiota and obesity Clin Microbiol Infect 19 2013 305 313
175. V.K. Ridaura, J.J. Faith, F.E. Rey, and et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice Science 341 2013 1241214
176. W.L. Hao, and Y.K. Lee Microflora of the gastrointestinal tract: a review Methods Mol Biol 268 2004 491 502
177. P.B. Eckburg, E.M. Bik, C.N. Bernstein, and et al. Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
178. A. Damms-Machado, S. Mitra, A.E. Schollenberger, and et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption Biomed Res Int 2015 2015 806248
179. G. Clarke, R.M. Stilling, P.J. Kennedy, C. Stanton, J.F. Cryan, and T.G. Dinan Minireview: Gut microbiota: the neglected endocrine organ Mol Endocrinol 28 2014 1221 1238
180. L.E. Scheepers, J. Penders, C.A. Mbakwa, C. Thijs, M. Mommers, and I.C. Arts The intestinal microbiota composition and weight development in children: the KOALA Birth Cohort Study Int J Obes (Lond) 39 2015 16 25
181. S.J. Kallus, and L.J. Brandt The intestinal microbiota and obesity J Clin Gastroenterol 46 2012 16 24
182. F. Backhed, J.K. Manchester, C.F. Semenkovich, and J.I. Gordon Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc Natl Acad Sci U S A 104 2007 979 984
183. S. Mandard, F. Zandbergen, E. van Straten, and et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity J Biol Chem 281 2006 934 944
184. A.J. Bruce-Keller, J.M. Salbaum, M. Luo, and et al. Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity Biol Psychiatry 77 2015 607 615
185. E. Schéle, L. Grahnemo, F. Anesten, A. Hallén, F. Bäckhed, and J.O. Jansson Regulation of body fat mass by the gut microbiota: Possible mediation by the brain Peptides 2015 http://dx.doi.org/10.1016/j.peptides.2015.03.027 [Epub ahead of print]
186. T.E. Sweeney, and J.M. Morton The human gut microbiome: a review of the effect of obesity and surgically induced weight loss JAMA Surg 148 2013 563 569
187. M. Boesjes, and G. Brufau Metabolic effects of bile acids in the gut in health and disease Curr Med Chem 21 2014 2822 2829
188. R. Kohli, K.D. Setchell, M. Kirby, and et al. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery Endocrinology 154 2013 2341 2351
189. H. Duboc, Y. Tache, and A.F. Hofmann The bile acid TGR5 membrane receptor: from basic research to clinical application Dig Liver Dis 46 2014 302 312
190. G.S. Gerhard, A.M. Styer, G.C. Wood, and et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass Diabetes care 36 2013 1859 1864
191. H.E. Bays Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development Expert Rev Cardiovasc Ther 9 2011 265 277
192. P.D. Cani, J. Amar, M.A. Iglesias, and et al. Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
193. P.D. Anderson, N.N. Mehta, M.L. Wolfe, and et al. Innate immunity modulates adipokines in humans J Clin Endocrinol Metab 92 2007 2272 2279
194. S.V. Monte, J.A. Caruana, H. Ghanim, and et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus Surgery 151 2012 587 593
195. P. Holzer, and A. Farzi Neuropeptides and the microbiota-gut-brain axis Adv Exp Med Biol 817 2014 195 219
196. G.J. Dockray Enteroendocrine cell signalling via the vagus nerve Curr Opin Pharmacol 13 2013 954 958
197. A.J. Montiel-Castro, R.M. Gonzalez-Cervantes, G. Bravo-Ruiseco, and G. Pacheco-Lopez The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality Front Integr Neurosci 7 2013 70
198. M. Matsumoto, R. Kibe, T. Ooga, and et al. Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study Front Syst Neurosci 7 2013 9
199. C. Yurdaydin, T.J. Walsh, H.D. Engler, and et al. Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy Brain Res 679 1995 42 48
200. S.D. Malnick, E. Melzer, M. Attali, G. Duek, and J. Yahav Helicobacter pylori: friend or foe? World J Gastroenterol 20 2014 8979 8985
201. M. Carabotti, C. D'Ercole, A. Iossa, E. Corazziari, G. Silecchia, and C. Severi Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery World J Gastroenterol 20 2014 647 653
202. C.H. Kim, J. Park, and M. Kim Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation Immune Netw 14 2014 277 288
203. M. Kasubuchi, S. Hasegawa, T. Hiramatsu, A. Ichimura, and I. Kimura Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation Nutrients 7 2015 2839 2849
204. M. Blaut Gut microbiota and energy balance: role in obesity Proc Nutr Soc 74 2015 227 234
205. T. Kawasaki, M. Ohta, Y. Kawano, and et al. Effects of sleeve gastrectomy and gastric banding on the hypothalamic feeding center in an obese rat model Surg Today 45 2015 1560 1566